Vanguard Group’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$335M Buy
7,131,004
+48,423
+0.7% +$2.28M 0.01% 1252
2025
Q1
$313M Sell
7,082,581
-76,290
-1% -$3.37M 0.01% 1252
2024
Q4
$259M Buy
7,158,871
+445,593
+7% +$16.1M ﹤0.01% 1414
2024
Q3
$215M Buy
6,713,278
+168,865
+3% +$5.41M ﹤0.01% 1505
2024
Q2
$247M Buy
6,544,413
+15,088
+0.2% +$568K ﹤0.01% 1379
2024
Q1
$321M Buy
6,529,325
+492,783
+8% +$24.3M 0.01% 1249
2023
Q4
$220M Buy
6,036,542
+1,114,080
+23% +$40.7M ﹤0.01% 1457
2023
Q3
$114M Buy
4,922,462
+20,651
+0.4% +$477K ﹤0.01% 1734
2023
Q2
$129M Buy
4,901,811
+493,284
+11% +$12.9M ﹤0.01% 1716
2023
Q1
$113M Buy
4,408,527
+86,172
+2% +$2.22M ﹤0.01% 1772
2022
Q4
$112M Buy
4,322,355
+1,126,310
+35% +$29.3M ﹤0.01% 1746
2022
Q3
$91.2M Buy
3,196,045
+451,928
+16% +$12.9M ﹤0.01% 1842
2022
Q2
$67.6M Sell
2,744,117
-136,869
-5% -$3.37M ﹤0.01% 2043
2022
Q1
$163M Buy
2,880,986
+18,674
+0.7% +$1.05M ﹤0.01% 1671
2021
Q4
$177M Buy
2,862,312
+154
+0% +$9.55K ﹤0.01% 1681
2021
Q3
$182M Buy
2,862,158
+156,091
+6% +$9.9M ﹤0.01% 1667
2021
Q2
$223M Buy
2,706,067
+212,011
+9% +$17.5M 0.01% 1564
2021
Q1
$183M Buy
2,494,056
+1,222,911
+96% +$90M 0.01% 1631
2020
Q4
$92.2M Buy
1,271,145
+589,143
+86% +$42.7M ﹤0.01% 1863
2020
Q3
$32.5M Buy
682,002
+140,847
+26% +$6.71M ﹤0.01% 2237
2020
Q2
$22.7M Buy
541,155
+88,742
+20% +$3.73M ﹤0.01% 2360
2020
Q1
$12.2M Buy
452,413
+62,857
+16% +$1.7M ﹤0.01% 2520
2019
Q4
$15M Buy
389,556
+319,556
+457% +$12.3M ﹤0.01% 2664
2019
Q3
$1.52M Buy
+70,000
New +$1.52M ﹤0.01% 3533